Influenza Vaccine Starting Age
Influenza vaccination should be administered starting at 6 months of age 1, 2, 3, 4, 5, 6.
Key Age-Based Recommendations
Minimum Age for Vaccination
- 6 months: This is the minimum age for all inactivated influenza vaccines (IIV) and recombinant influenza vaccines (RIV) 1, 3, 4
- 2 years: Minimum age for live attenuated influenza vaccine (LAIV) administered intranasally 1, 3, 4
- 9 years: Minimum age for recombinant influenza vaccine (RIV3/Flublok) as of the 2025-2026 season 5, 6
Dosing Schedule by Age
Children 6 months through 8 years:
Require 2 doses (minimum 4 weeks apart) if:
Require 1 dose if:
Children 9 years and older:
Dose Volumes by Age
For children 6-35 months:
- Most vaccines: 0.5 mL per dose 1, 4
- Afluria: 0.25 mL per dose (must be drawn from multidose vial; prefilled syringes not available for this age) 1, 3
- Fluzone: Either 0.25 mL or 0.5 mL per dose is acceptable 1, 3
For children ≥36 months (≥3 years):
Clinical Implementation Pearls
Timing Considerations
- Start early: Children requiring 2 doses should receive their first dose as soon as vaccine becomes available (including July-August) to allow adequate time for the second dose before influenza season peaks 1, 4
- Optimal timing: Ideally complete vaccination by end of October 4, 6
- Extended season: Continue offering vaccination throughout the influenza season, even into late winter and early spring, as influenza activity often extends into March 7
Common Pitfalls to Avoid
- Don't delay for specific products: Administer whatever age-appropriate vaccine is available rather than waiting for a preferred formulation 2, 4
- Don't split doses: A 0.5-mL dose should not be split into two 0.25-mL doses 4
- Age-appropriate formulations: Ensure the correct dose volume is used—administering an adult formulation to a young child counts as valid, but underdosing requires correction 2, 4
- Mixed vaccine types: When 2 doses are needed, they don't need to be the same brand or formulation (IIV, LAIV, or RIV can be mixed if age-appropriate) 4, 6
High-Priority Groups
While vaccination is recommended for all children ≥6 months, special emphasis should be placed on:
- Children <5 years (especially <2 years) who have higher hospitalization rates 4, 6
- Children with chronic medical conditions (asthma, cardiac disease, immunocompromise, diabetes, etc.) 2
- Household contacts of infants <6 months who cannot yet be vaccinated 5, 6
Contraindications by Age
- LAIV cannot be used in children <2 years or adults >49 years 1, 3
- RIV was not approved for children <18 years until recently; now approved for ≥9 years as of 2025-2026 season 5, 6
The bottom line: Begin annual influenza vaccination at 6 months of age, ensure children 6 months through 8 years receive appropriate number of doses based on vaccination history, and prioritize early vaccination to maximize protection before peak influenza season 1, 3, 4, 6.